Cerebral Aneurysms
0
Pipeline Programs
4
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Providence TherapeuticsAB - Calgary
1 programRegistry for Study of Coils in Intracranial AneurysmsN/A
Angeles TherapeuticsCA - Los Angeles
1 programRegistry for Study of Coils in Intracranial AneurysmsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
CerusContour Neurovascular System Treatment Attempt
Angeles TherapeuticsRegistry for Study of Coils in Intracranial Aneurysms
Clinical Trials (2)
Total enrollment: 364 patients across 2 trials
Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)
Start: Jun 2025Est. completion: Jan 2030250 patients
N/ARecruiting
Registry for Study of Coils in Intracranial Aneurysms
Start: Aug 2009Est. completion: Dec 2016114 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 364 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.